Q: Long term holder of CGI in RSP account, and although it’s performed decent enough, I’m looking for more growth. Which of DSG or ENGH would you recommend switching to, or would 1/2 position in both make more sense?
Thank you.
Q: Hello,
I have cash in my RRSP to buy an initial position in one of these companies. Growth focus, with a chance to double the share price in a 5-year timeline approx. Morningstar rates both as "undervalued".
On TOI, on April 1st you mentioned two funds have recently bought-in (Fidelity and Akre). TOI has now run up 20% in the last 3 weeks, ahead of the May 5 call and their first reporting as a public co. It feels like the smart money knows there is good performance coming on TOI, near-term and further out, with its parent company providing support. If you were picking just one of these...
Q: I picked up a full position in KXS at just the wrong time ($190) and am down 17%. I'm wondering about the wisdom of selling and and putting the money into SHOP or LSPD with an eye on a better rebound. I have a 5+ time frame. I know they are different industries I'm just looking within the bounds of the Technology sector.
I have a 4% position in ABST and 4% position in SYZ. Looking for both income and growth. I'm considering selling all my ABST and buying more SYZ. (Dividend is higher for the latter) Is there any reason to continue to hold ABST or would the above trade make sense?
Q: Hi, there is a lot of love for TDOC and it has grown quickly. I used to own it but sold, and am revisiting and researching the name. The main concern I have is reports that whales like Amazon and Wallmart, etc. are moving into the area of digital health. Amazon Care in particular, while currently a pilot project in Washington for Amazon employees, could expand if they see potential. Since TDOC is at a very high multiple to sales, I question the risk/reward here, can you please comment on your perspective? Would this risk also apply to WELL, which I own?
Q: Hi,
I realize pre-IPO questions are challenging to answer but here goes. I've been reading about Telesat's plans to go public on the NASDAQ later this year "looking to raise new capital for its ambitious multibillion-dollar plan to launch hundreds of low-Earth orbit satellites." They will be used to provide high speed internet. This will put it in direct competition with Elon Musk's Starlink and Jeff Bezo's Kuiper Project, reportedly at half the cost (~$5B vs. ~$10B each for the others). Do you have any very early comments on the opportunity?
Thank you, Michael
Q: Looks like MTRX (Loop) is getting involved with LSPD (Lightspeed). This should give them a big boost. I am wondering about your thoughts o. MRTX
Thanks James
Q: Hi 5i team,
I have XBC in my TFSA with a 50% loss. As you mentioned before, it probably will take about a year for the company to prove itself. There won’t be much upside for this stock in the near future. In order to put the money to better use, I’m going to sell XBC now and use the proceeds to purchase another company hopefully at the cusp of positive move. I’m thinking of ATA / EGLX / MCR from the Growth Portfolio. I’m looking for high revenue growth and strong cash flow. Which of these do you think have the most upside potential in the next 12 months and why or would you suggest another name? Thanks.
Q: I'm looking at the rebound in these tech and consumer discretionary stocks and wondering whether you have a preference for some of these companies over others. Could you please rank your favourites based on risk/reward to buy now, and would you recommend trading any to exchange for others? I have holdings in most.
Q: C3ai is now dropped 65% from it high, yet it appears to have a viable business. May I have your analysis of this company as a possible investment?
With appreciation,
Ed
Q: Does CSU maintain an economic interest in Topicus? Based on my review of the final long form prospectus for Topicus and insider reporting it looks like CSU holds voting control and a significant number of pref shares in Topicus. What I'm trying to confirm is whether I need to buy Topicus to obtain exposure to its growth or whether as a CSU holder I will already have some exposure.